Pharmaceutical products

Description:: Supply of various pharmaceutical products over a 12-month period including POLATUZUMAB VEDOTIN, GUSELKUMAB, Immunoglobulins, Paclitaxelum, FARICIMAB, Ryboflavin, CEMIPLIMAB, LENALIDOMIDE, BEVACIZUMAB, BLINATUMOMAB, OZANIMOD, LUSPATERCEPT, BRENTUXIMAB VEDOTIN, IVACAFTOR + TEZACAFTOR, CYTARABINE + DAUNORUBICIN.

Awarded to:: BLINATUMOMAB; Amgen Sp. z o.o., Warszawa (PL); BEVACIZUMAB; Bialmed Sp. z o.o., Warszawa (PL); Ryboflawina do Cross-linkingu; CENTRALA FARMACEUTYCZNA CEFARM SA, Warszawa (PL); GUSELKUMAB; Janssen - Cilag Polska sp. z o.o., Warszawa (PL); LENALIDOMIDE; Komtur Polska Sp. z o.o., Warszawa (PL); IVACAFTOR + TEZACAFTOR, CYTARABINE + DAUNORUBICIN; Komtur Polska Sp. z o.o., Warszawa (PL); POLATUZUMAB VEDOTIN; Roche Polska Sp. z o.o., Warszawa (PL); FARICIMAB; Roche Polska Sp. z o.o., Warszawa (PL); Paclitaxelum; Salus International Sp. z o.o., Katowice (PL); CEMIPLIMAB; Sanofi-Aventis Sp. z o.o., Warszawa (PL); Immunoglobulina ludzka normalna; Takeda Pharma Sp. z o.o., Warszawa (PL); BRENTUXIMAB VEDOTIN; Takeda Pharma Sp. z o.o., Warszawa (PL); OZANIMOD; Urtica Sp. z o.o., Wrocław (PL); LUSPATERCEPT; Urtica Sp. z o.o., Wrocław (PL)